Skip to main content
< All Topics
Print

EFTA01613818: Jeffrey Epstein’s July 2016 Medical Messages With Bruce Moskowitz

Snapshot

EFTA01613818 is an eight page iMessage export covering July 25 through July 28, 2016. It records a medical discussion between Jeffrey Epstein and physician Bruce Moskowitz. Epstein describes a range of symptoms, sends photographs, discusses tests and other doctors, and reports that repeated gonorrhea results were positive. Moskowitz replies that a prescription is needed and says he will give Epstein a ceftriaxone injection the following day.

The exchange is unusually detailed evidence of Epstein’s medical care. It documents what the participants wrote and what treatment Moskowitz proposed. The visible pages do not include the underlying laboratory report or confirm that the injection occurred.


Key Takeaways

  • Epstein sent Moskowitz photographs while discussing redness and changes in the appearance of his skin.
  • In a July 26 message, Epstein summarized symptoms, reported test results, listed medications, and named doctors involved in his care.
  • The exchange mentions possible prostate imaging, a cystoscope, further blood work, and treatment for a reported parasitic infection. These were discussions and reported recommendations, not proof that every procedure occurred.
  • On July 28, Epstein sent a PDF attachment identified as “Epstein 72816.pdf.” The attachment’s contents are not visible in this eight page export.
  • Epstein then wrote that gonorrhea was positive on three repeated tests. Moskowitz responded that treatment was needed and proposed a ceftriaxone injection for the next day.
  • Nothing in this exchange identifies a sexual partner, establishes how an infection was acquired, or connects any other person to the reported result.

The Record and Its Participants

The first page identifies the platform as iMessage and displays the export’s timezone as UTC+0000. Its participant header includes Bruce Moscowitz, the address jeeitunes@gmail.com, and a redacted participant field. The messages and related reporting identify the physician as Bruce Moskowitz, although the displayed contact spelling differs.

The messages attributed here to Epstein are the outgoing messages in this export. That attribution is supported by the account context and by the attachment bearing his name. The redacted participant field limits what can be established from the header alone.

The eight pages bear consecutive identifiers from EFTA01613818 through EFTA01613825. They should be read together as one released conversation segment.


July 25: Photograph and Redness

On page one, EFTA01613818, the outgoing participant sends a photograph showing part of a torso. He describes a red outline of veins. Moskowitz asks whether the appearance went away and returned or stayed the same. The reply says it became lighter and darker but never entirely disappeared.

The photograph and text document what Epstein showed and reported to his physician. They do not establish a diagnosis or the cause of the visible appearance.


July 26: Epstein’s Summary of Symptoms and Care

On EFTA01613819, Epstein sends Moskowitz a long summary. He lists swelling he calls angioedema, a pattern on his abdomen, brain fog, swollen sinuses, apnea, a lumbar spine concern, urinary symptoms, low libido, and previously reported blood test findings. He says earlier bladder imaging was negative and describes urine and semen cultures as negative.

He also reports two positive parasite findings associated with a doctor he calls Cahill. He lists medications and supplements, including Medrol, Claritin, Zantac, and magnesium. These are Epstein’s statements in a message. The eight page export does not contain the underlying test results for each item.

Epstein says a doctor whose name appears as “tawari” found little and suggested a prostate MRI. He also mentions a cystoscope and a possible older stricture, while saying an office procedure had been too uncomfortable. The spelling in the message should not be silently treated as definitive identification of the physician.

Moskowitz replies that he tried calling. A later photograph on the same page shows an area of reddened skin. On EFTA01613820, Epstein describes new redness and says no cat was around. That detail records one circumstance he thought relevant; it does not identify the cause of the redness.

On EFTA01613821, Epstein sends a mirror photograph showing his torso and tells Moskowitz that he can zoom in. Moskowitz says an unnamed woman is away that week. Epstein asks whether he should take tinidazole, saying Cahill wants him to do so. Moskowitz answers, “Ok.” The visible messages do not establish whether Epstein took the medication.


July 27 and 28: Blood Work and Additional Symptoms

On EFTA01613822, Epstein describes something as being “under the skin.” Moskowitz says he will try to reach the unnamed woman on Monday. The exchange does not identify her or explain her role.

On EFTA01613823, Epstein says Dr. Kline is sending him for blood work and asks Moskowitz what to add. Moskowitz requests tests described as cold agglutinins, warm agglutinins, and a lupus panel. The pair then exchange messages about sending the request to Quest. The export records the request and their messages about transmission; it does not show the resulting laboratory report.

On EFTA01613824, Epstein reports slightly elevated eosinophils and a small amount of blood in urine. He says he is taking Tindamax for a parasite and expects to be in Palm Beach the following day. He also asks whether he seems to be losing his sense of smell. Moskowitz replies, “Allergy for eosinophils.” These statements should be read as part of an ongoing clinical conversation, without treating this excerpt as a complete medical assessment.


July 28: The Reported Gonorrhea Result

The final page, EFTA01613825, is the most consequential part of the exchange. At 4:34 p.m. in the export, Epstein sends an attachment listed as “Epstein 72816.pdf,” with a displayed size of 44 KB. About one minute later, he reports that gonorrhea was positive on three repeats.

Moskowitz later replies, “Positive need Rx.” He then writes that he will give Epstein a ceftriaxone injection in the office the next day. The visible export supports a narrow conclusion: Epstein reported a repeated positive result, and Moskowitz proposed treatment. Because the attached PDF is not reproduced in these pages, this file alone does not permit an independent review of the laboratory findings. It also does not show a visit or medication administration on July 29.

Gonorrhea is a sexually transmitted infection. A reported infection does not, by itself, establish the identity of a partner, the circumstances of transmission, or misconduct involving another person.


Relationship to Other Moskowitz Records

The July 2016 exchange documents Moskowitz responding to Epstein’s personal health concerns across several days. A separate medical professionals investigation hosted by Epstein Data identifies additional Moskowitz communications, including a January 2018 discussion about gonorrhea and two unnamed people. That report is a research aid. Each separate claim must be checked against its own underlying EFTA document.

The 2018 conversation is not part of EFTA01613818. The 2016 positive result cannot be used to identify the two people mentioned later, infer that they had contact with Epstein in 2016, or establish a continuing infection.

EpsteinWiki also records Bruce and Marsha Moskowitz in arrangements for a later Zorro Ranch stay. That is a separate relationship documented by different records. Neither a medical consultation nor a property visit establishes knowledge of Epstein’s abuse.


What Remains Unverified

The released conversation leaves several material questions open:

  • What does the attached “Epstein 72816.pdf” contain, and is a public copy available?
  • Do separate laboratory records confirm the results Epstein described?
  • Did the proposed July 29 office visit and injection take place?
  • What were the final findings of the additional blood tests requested on July 27?
  • Who was the unnamed woman Moskowitz said was away, and what was her role in the medical discussion?

These questions matter because a message reporting a result, an attached test report, a clinician’s interpretation, and a record of completed treatment are different kinds of evidence.


Evidence Appearances

  • EFTA01613818: July 25 torso photograph and discussion of redness.
  • EFTA01613819: July 26 symptom summary and photograph of reddened skin.
  • EFTA01613820: Message about new redness.
  • EFTA01613821: Mirror photograph and discussion of tinidazole.
  • EFTA01613822: Further description of a skin concern.
  • EFTA01613823: Discussion of additional blood tests.
  • EFTA01613824: Reported blood findings, medication, travel plans, and change in sense of smell.
  • EFTA01613825: PDF attachment entry, reported gonorrhea results, and proposed treatment.

Questions Raised by the Record

  • Where is the original July 28 attachment, and can it be matched to this message without relying on its filename alone?
  • Are there subsequent messages or appointment records documenting the proposed treatment?
  • Can the reported test results and specialist recommendations be checked against original clinical records?
  • What does the complete Moskowitz conversation add to the context of this eight page segment?

Sources

Previous EFTA00313848: California Cryobank Liability and Specimen Control Terms Signed by Jeffrey Epstein
Next EFTA01660671: An Unidentified Chest Radiograph in the Epstein Files
Table of Contents